Home NDC 50419-397-01 HYRNUO
Product NDC 50419-397
Requested package NDC 50419-397-01
11-digit product format 504190397
Labeler code 50419
Product ID 50419-397_2ba86679-0db2-44b4-86d1-e69413e24762
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name SEVABERTINIB
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Bayer HealthCare Pharmaceuticals Inc.
Application NDA219972
Marketing category NDA
Marketing start 2025-11-19
Substance SEVABERTINIB
Active strength 10 mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219972-001 HYRNUO SEVABERTINIB 10MG TABLET / ORAL RLD, RS 2025-11-19
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 N219972-001 12679836 2043-11-14 U-4582 Drug substance, Drug product 2026-08-10
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219972-001 NCE 2030-11-19 N219972-001 ODE-560 2032-11-19 N219972-001 ODE-561 2033-09-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219972-001 HYRNUO 10MG TABLET / ORAL RLD, RS 2025-11-19 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219972-001 12679836 2043-11-14 U-4582 Drug substance, Drug product 2026-08-10 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219972-001 12679836 2043-11-14 U-4582 Drug substance, Drug product 2026-08-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219972-001 12679836 2043-11-14 U-4582 Drug substance, Drug product 2026-08-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219972-001 12679836 2043-11-14 U-4582 Drug substance, Drug product 2026-08-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219972-001 10428063 2036-01-25 Drug substance, Drug product 2025-12-09 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219972-001 10428063 2035-10-10 Drug substance, Drug product 2025-12-09 a50c72e98297…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base HYRNUO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SEVABERTINIB 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2A7VPM5RWH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2728192 Internal RxNorm lookup 2728198 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50419-397-01 HYRNUO 120 in 1 BOTTLE TABLET, FILM COATED 120 8
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 50419-397-01 50419039701 120 TABLET, FILM COATED in 1 BOTTLE (50419-397-01) 2025-11-19 No No Current